Search results - 357 results
Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer
cancer screening data and the national cancer registry, demonstrates excellent protection against invasive cervical cancer among girls immunized at the age of 12 to 13 years with the bivalent human ...
Protection conferred by an H5 DNA vaccine against highly pathogenic avian influenza in chickens: The effect of vaccination schedules.
full clinical protection and a significant or complete reduction of viral shedding against homologous challenge at 6 and 25 weeks of age. The heterologous clade 2.3.4.4b challenge of 6-week-old chickens ...
Full Characterisation of Heroin Samples Using Infrared Spectroscopy and Multivariate Calibration
Volume 29, Issue 5 (2024) Keywords: adulterants; ATR-IR; chemometrics; diacetylmorphine; diluents; mobile detection approaches Abstract: The analysis of heroin samples, before use in the protected ...
Coadministered pneumococcal conjugate vaccine decreases immune response to hepatitis A vaccine: a randomized controlled trial.
considered protective was reached by 71 of 85 (83.5%) in the PCV13 +HepA group versus 76 of 79 (96.2%) in the HepA group, p 0.008. The increases in anti-pneumococcal IgG and OPA levels were comparable in the ...
Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries
estimate, between February and March 2023, the first booster (mostly administered >24 weeks) showed little to no added protection: rVE estimates ranged between-13–17%, among the different age groups. VE ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
maintaining protection against COVID-19 hospitalisation and death, in the context of decreasing VE over time. Multicountry data from EHR facilitate robust near-real-time VE monitoring in the EU / EEA and ...
Exploratory study of risk factors related to SARS-CoV-2 prevalence in nursing homes in Flanders (Belgium) during the first wave of the COVID-19 pandemic
linear models and Bayesian linear regression. The present analyses showed that the prevalence of residents with dementia, the scarcity of personal protective equipment (surgical masks, FFP2 masks, glasses ...
Release of Nano-objects, their aggregates and agglomerates from Masks: ambitions and scientific objectives of the RENAAME project
de masques (chirurgicaux, de protection respiratoire FFP x et à usage non sanitaire). Pour la fabrication de ces différents types de masques, l’ajout de nanomatériaux représente une voie majeure ...
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.
protection, infections occurring before 2021 remained associated with significant risk reduction against symptomatic infection. Vaccination and prior infection outperformed vaccination or prior infection ...
Factors underlying COVID-19 booster vaccine uptake among fully vaccinated adults in Belgium
waning protection against severe COVID-19 infection, booster doses of the COVID-19 vaccines were recommended among individuals who received their primary course. A first COVID-19 vaccine booster campaign ...